Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific

The Asia Pacific GI endoscopy device market was negatively impacted by the COVID-19 pandemic. Following recovery, the market will grow moderately throughout the forecast period, mainly due to the efficiency of nationwide CRC and GI cancer screening programs, especially in Australia and South Korea, the high incidence of gastric cancer and CRC cases in the region, the increasing uptake of GI endoscopy devices among physicians due to training programs and conferences, and the improving healthcare infrastructure, especially in China and India. However, ASP declines due to price-based competition will continue to hamper some segments within the Asia Pacific GI endoscopy devices market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Asia Pacific from 2019 through 2032.

The COVID-19 pandemic has affected the Asia Pacific GI endoscopy device market.

To what extent has the COVID-19 pandemic impacted the market in the Asia Pacific region?

Which procedures have been affected the most during the pandemic?

When is the market expected to recover?

How has the pandemic impacted the adoption of innovative technologies such as capsule endoscopes?

The nationwide CRC and GI cancer screening programs and supportive clinical recommendations have aided growth of the market.

Which countries saw a positive impact on procedure volumes from the nationwide CRC and GI cancer screening programs?

Which geographies host a favorable regulatory environment for the growth of the GI endoscopy market?

Concerns surrounding the contamination of reprocessed endoscopes, especially duodenoscopes, coupled with technological innovations and launches have supported the uptake of disposable GI videoscope systems in the Asia Pacific region.

How has the contamination risk from reprocessed duodenoscopes impacted the market?

What clinical recommendations and guidelines have been issued by the regulatory bodies in the region?

What strategies have the competitors adopted to address these issues?

What are the latest innovations that could mitigate the risk of infection?

The integration of AI and CAD has improved the scope of innovation in the Asia Pacific GI endoscopy device market.

Which companies are investing in AI and CAD?

How is the incorporation of AI and CAD into endoscopy impacting the GI endoscopy device market?

The Asia Pacific GI endoscopy device market is dominated by large international competitors, but domestic manufacturers will increase their presence over the forecast period.

How much market share do MNCs hold in each segment?

In which geographies, is there strong domestic competition?

What strategies are domestic manufacturers employing to compete in the Asia Pacific GI endoscopy device market?

To what extent are domestic manufacturers penetrating their local markets?

Table of contents